Comments: 0 | June 28th, 2011

, You may have heard reports in the media over the past couple of days that the pharmaceutical drug giant, Pfizer, is at it again with . The drug, Aromasin, was used in a study of 4,560 post-menopausal women who had an increased risk of breast cancer. The study showed that the women who took the drug, which is an estrogen-blocker, had fewer invasive breast cancers after 3 years. Anyone want to guess who helped fund the study?
 , While we wish preventing breast cancer was as easy as taking a pill, the truth is that it’s not. Neither breast cancer, nor any cancer, is caused by low levels of pharmaceutical drugs in the body. Rather, balancing the body’s hormones and practicing a healthy lifestyle are essential steps for breast cancer prevention.

For suggestions on how women can protect themselves against breast cancer without the use of pharmaceutical drugs, check out this recent post on breast cancer prevention.
 , Although we are pleased to hear that the media is reporting on breast cancer prevention rather than just detection, the focus on pharmaceutical “solutions” proves they are still missing the mark.